Determinants of vancomycin nephrotoxicity when administered to outpatients as a continuous 24 hour infusion.
Sign Up to like & getrecommendations! Published in 2020 at "International journal of antimicrobial agents"
DOI: 10.1016/j.ijantimicag.2020.105972
Abstract: Vancomycin, administered by continuous infusion, (VCI) is used to treat serious gram positive infections in outpatients. We retrospectively investigated the rate of nephrotoxicity and associated risk factors in outpatients on VCI between May 2013 and… read more here.
Keywords: infusion; weighted average; serum creatinine; vancomycin concentration ... See more keywords
Initial Serum C-reactive Protein Level as a Predictor of Increasing Serum Vancomycin Concentration During Treatment.
Sign Up to like & getrecommendations! Published in 2021 at "Therapeutic Drug Monitoring"
DOI: 10.1097/ftd.0000000000000870
Abstract: BACKGROUND AND AIM Vancomycin has a narrow therapeutic window, and an increase in its serum concentration/dose ratio during treatment can cause renal toxicity. Therefore, this study was aimed at finding a marker to identify patients… read more here.
Keywords: serum; concentration dose; treatment; vancomycin concentration ... See more keywords
O-13 Factors impacting unbound vancomycin concentrations in neonates and young infants
Sign Up to like & getrecommendations! Published in 2017 at "Archives of Disease in Childhood"
DOI: 10.1136/archdischild-2017-esdppp.13
Abstract: Background Vancomycin, a glycopeptide, is often ad-ministered to treat (suspected) serious gram-positive in-fections caused by Staphylococci, including methicillin-re-sistant Staphylococcus aureus (MRSA) and coagulase-neg-ative Staphylococci (CoNS). Vancomycin pharmacokinetic (PK) and pharmacodynamic (PD) data in neonates are… read more here.
Keywords: vancomycin; vancomycin concentration; neonates young; young infants ... See more keywords